Abstract
Telomerase adds hexameric repeats of 5′-TTAGGG-3′ termed telomeres to ends of chromosomal DNA. This enzyme has been implicated in cellular immortalization and cellular senescence. Recently, a number of relevant genes have been cloned, including these encoding three major components of human telomerase: human telomerase RNA component (hTR), human telomerase reverse transcriptase (hTERT), and telomerase-associated protein-1 (TEP1). Also important are genes encoding human telomeric-repeat binding factor protein (TRF) 1 and 2. To clarify mechanisms regulating telomerase activity, we studied telomerase activity, the telomeric restriction fragment (TRF) length and gene expression of these telomerase components and the telomeric-repeat binding factor proteins in sequential observation following X-irradiation of cultured pancreatic cancer cells. We previously reported that PANC-1 cells are better able to tolerate thermal stress, antineoplastic drugs, and exposure to tumour necrosis factor than MIAPaCa-2 cells. MIAPaCa-2 and PANC-1 cells were exposed to X-irradiation, their telomerase activity was increased at 2 days and then decreased gradually. Of the three telomerase components, only hTERT mRNA expression showed parallel changes. TRF length was stable just before and after X-irradiation. Among binding factor proteins, TRF1 mRNA showed reciprocal changes possibly directed toward maintaining a stable telomere length. In this study, our results demonstrate that not only hTERT but also TRF1 are important regulator of telomerase activity. © 2001 Cancer Research Campaign www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bodnar, AG, Ouellette, M, Frolkis, M, Holt, SE, Chiu, CP, Morin, GB, Harley, CB, Shay, JW, Lichtsteiner, S & Wright, WE (1998). Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349–352.
Broccoli, D, Smogorzewska, A, Chong, L & De Lange, T (1997). Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet, 17, 231–235.
Chong, L, van Steensel, B, Broccoli, D, Erdjument-Bromage, H, Hanish, J, Tempst, P & de Lange, T (1995). A human telomeric protein. Science, 270, 1663–1667.
Counter, CM, Avilion, AA, Lefeuvre, CE, Stewart, NG, Greider, CW, Harley, CB & Bacchetti, S (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J, 11, 1921–1929.
Feng, J, Funk, WD, Wang, SS, Weinrich, SL, Avilion, AA, Chiu, CP, Adams, RR, Chang, E, Allsopp, RC, Yu, J, LES West, MD, Harley, CB, Andrews, WH, Greider, CW & Villeponteau, B (1995). The RNA component of human telomerase. Science, 269, 1236–1241.
Greider, CW & Blackburn, EH (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405–413.
Griffith, JD, Comeau, L, Rosenfield, S, Stansel, RM, Bianchi, A, Moss, H & de Lange, T (1999). Mammalian telomeres end in a large duplex loop. Cell, 97, 503–514.
Hande, MP, Lansdorp, PM & Natarajan, AT (1998). Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing. Mutat Res, 404, 205–214.
Harrington, L, Mcphail, T, Mar, V, Zhou, W, Oulton, R, Program, AE, Bass, MB, Arruda, L & Robinson, MO (1997). A mammalian telomerase-associated protein. Science, 275, 973–977.
Hiyama, E, Gollahon, L, Kataoka, T, Kuroi, K, Yokohama, T, Gazder, AF, Hiyama, K, Piatyszek, MA & Shay, JW (1996). Telomerase activity in human breast cancer. J Nat Cancer Inst, 88, 116–122.
Hyeon Joo, O, Hande, MP, Lansdorp, PM & Natarajan, AT (1998). Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res, 401, 121–131.
Ito, H, Kyo, S, Kanaya, T, Takamura, M, Inoue, M & Namiki, M (1998). Expression of human telomerase catalytic subunits and correlation with telomerase activity in urotherial cancer. Clin Cancer Res, 4, 1603–1608.
Kim, NW, Piatyszek, MA, Prowse, KP, Harley, CB, West, MD, Ho, PL, Coviello, GM, Wright, WE, Weinrich, SL & Shay, JW (1994). Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011–2015.
Kim, NW & Wu, F (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res, 25, 2595–2597.
Kolquist, KA, Ellisen, LW, Counter, CM, Meyerson, M, Tan, LK, Weinberg, RA, Haber, DA & Gerald, WL (1998). Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet, 19, 182–186.
Kyo, S, Kanaya, T, Takakura, M, Tanaka, M, Yamashita, A, Inoue, H & Inoue, M (1999). Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer, 80, 804–809.
Meyerson, M, Counter, CM, Eaton, EN, Ellisen, LW, Steiner, P, Caddle, SD, Ziaugra, L, Beijersbergen, RL, Davidoff, MJ, Liu, Q, Bacchetti, S, Haber, DA & Weinberg, RA (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785–795.
Nakamura, TM, Morin, GB, Chapman, KB, Weinrich, SL, Andrews, WH, Lingner, J, Harley, CB & Cech, TR (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955–959.
Nakayama, J, Saito, M, Nakamura, H, Matsuura, A & Ishikawa, F (1997). TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell, 88, 875–884.
Nakayama, J, Tahara, H, Tahara, E, Saito, M, Ito, K, Nakamura, H, Nakanishi, T, Tahara, E, Ide, T & Ishikawa, F (1998). Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet, 18, 65–68.
Shay, JW & Bacchetti, S (1997). A survey of telomerase activity in human cancer. Eur J Cancer, 33, 787–791.
Takakura, M, Kyo, S, Kanaya, T, Tanaka, M & Inoue, M (1998). Expression of human telomerase subunits and correlation with cervical cancer. Cancer Res, 58, 1558–1561.
van Steensel, B & de Lange, T (1997). Control of telomere length by the human telomeric protein TRF1. Nature, 385, 740–743.
van Steensel, B, Smogorzewska, A & de Lange, T (1998). TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401–413.
Vaziri, H & Benchimol, S (1998). Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol, 8, 279–282.
Watanabe, N, Tsuji, N, Tsuji, Y, Sasaki, H, Okamoto, T, Akiyama, S, Kobayashi, D, Sato, T, Yamauchi, N & Niitsu, Y (1996). Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells. Pancreas, 13, 395–400.
Watanabe, N, Tsuji, N, Kobayashi, D, Yamauchi, N, Akiyama, S, Sasaki, H, Sato, T, Okamoto, T & Niitsu, Y (1997). Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity in pancreatic carcinoma cells via enhancement of the heart shock element-binding activity of heart shock factor 1. Chemotherapy, 43, 406–414.
Weinrich, SL, Pruzan, R, Ma, L, Ouellette, M, Tesmer, VM, Holt, SE, Bodnar, AG, Lichtsteiner, S, Kim, NW, TRAGER, JB, Taylor, RD, Carlos, R, Andrews, WH, Wright, WE, Shay, JW, Harley, CB & Morin, GB (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet, 17, 498–502.
Yajima, T, Yagihashi, A, Kameshima, H, Kobayashi, D, Furuya, D, Hirata, K & Watanabe, N (1998). Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem, 44, 2441–2445.
Yajima, T, Yagihashi, A, Kameshima, H, Furuya, D, Kobayashi, D, Hirata, K & Watanabe, N (2000). Establishment of quantitative reverse transcription-polymerase chain reaction assays for human telomerase-associated genes. Clin Chim Acta, 290, 117–127.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yajima, T., Yagihashi, A., Kameshima, H. et al. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer 85, 752–757 (2001). https://doi.org/10.1054/bjoc.2001.1954
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1954
Keywords
This article is cited by
-
Non-canonical roles of canonical telomere binding proteins in cancers
Cellular and Molecular Life Sciences (2021)
-
PTOP and TRF1 help enhance the radio resistance in breast cancer cell
Cancer Cell International (2014)
-
Telomere Profiling: Toward Glioblastoma Personalized Medicine
Molecular Neurobiology (2013)
-
Analysis of hTERT mRNA expression in biliary tract and pancreatic cancer
Journal of Hepato-Biliary-Pancreatic Surgery (2007)
-
Cyclic Induction of Senescence with Intermittent AZT Treatment Accelerates both Apoptosis and Telomere Loss
Breast Cancer Research and Treatment (2005)